As announced previously by Holista, Path-Away® was successfully tested in April 2020 by a leading U.K. bio-safety laboratory. The tests confirmed Path-Away® to be 99.99% effective within one minute of use on the feline coronavirus, a recognised surrogate of SARS-CoV-2.
GICC and Holista have commenced additional tests at the Microbac Laboratories in Virginia, which is approved by the US Center for Diseases Control (“CDC”, on the human COVID-19 strain. The final audited test results are expected to be released in October 2020.
Ann: Pause in Trading, page-39
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HCT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.394M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $1.101K | 220.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1737805 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 414325 | 2 |
View Market Depth
| Last trade - 15.53pm 28/06/2024 (20 minute delay) ? |
| HCT (ASX) Chart |